The short answer: most misleading health news is not outright false but exaggerated, usually by reporting risk in the most dramatic way and by treating a single early study as settled fact. A few habits - asking about absolute risk, checking the study type, and spotting hype words - let you read health stories far more critically.
Relative versus absolute risk
This is the single most useful idea, because it explains most alarming or exciting headlines. Say a study reports that a habit 'doubles your risk' of a disease. That is the relative risk, and it sounds frightening. But if the disease affects, say, 1 in 10,000 people, doubling it means 2 in 10,000 - a tiny absolute change dressed up as a big one.
Whenever you see a percentage increase or decrease in risk, ask: increase from what to what? A '50% higher risk' is meaningless without the baseline. Reputable reporting gives you both the relative and the absolute figures; hype gives you only the scarier relative one. The same trick works in reverse for good news: a treatment that 'cuts your risk by a third' has done little if the risk was negligible to begin with, and a great deal if it was high, so the headline number alone never tells you whether to care.
What kind of study was it?
Not all evidence is equal, and the type of study shapes what it can and cannot show. Two distinctions do most of the work:
- Observational studies watch groups of people and look for associations. They can show that two things go together, but not that one causes the other - there may be other explanations.
- Randomised controlled trials (RCTs) deliberately assign people to different groups, which lets them test cause and effect far more reliably.
- A single study, of any type, is rarely the last word; systematic reviews that pool many studies are more trustworthy.
- Studies in animals or in a test tube are early-stage and often do not translate to humans, despite excited headlines.
So when a headline says a food is 'linked to' an outcome, that is usually observational: interesting, not proof. The classic confusion is mistaking correlation for causation, and we apply the same caution to nutrition claims in ultra-processed foods evidence and to the endless myths about metabolism that circulate online.
There is also a timing trap worth naming. The most newsworthy studies are often the first to report a surprising result, and early findings are the ones most likely to shrink or reverse when larger studies follow. This is not scientists getting it wrong; it is how the process is meant to work, with claims tested, refined and sometimes overturned over years. It does mean that the freshest, most dramatic headline is frequently the least reliable, and that settled advice, the kind you find on steady reference sites such as the NHS Live Well pages, changes slowly precisely because it reflects the weight of evidence rather than the newest single study.
Red flags for hype
Certain features reliably signal that a story is overselling its evidence. Be wary of single studies reported as definitive, dramatic claims resting on very small numbers of participants, results in mice presented as human news, and language promising a wonder cure or a simple fix for a complex problem. Words like 'breakthrough' and 'game-changer' are marketing, not science. The same scepticism applies to the mirror image: scare stories that a common food or habit will harm you, which follow exactly the same pattern of a single study, a relative-risk headline and no baseline.
Be cautious, too, of stories with no named source, no mention of study size, and no acknowledgement of limitations. Good science is full of caveats; hype strips them away.
Checking the source
When a story matters to you, go upstream. Reputable coverage names the journal and the researchers, and often links to the study. In the UK, the NHS runs a service, Behind the Headlines, that unpicks the science behind health stories, and organisations like NICE publish measured clinical guidance. It is also worth asking who funded the research and who benefits from the claim: a study of a product paid for by its maker warrants extra scepticism. This matters most for supplements and self-care products, where the same overselling patterns we see in immune system myths turn up again and again, and where the gap between a headline and the evidence is often widest.
A calm approach
The aim is not to distrust all health news but to read it with proportion. Single studies rarely change what you should do; consistent findings over time do. When a headline urges you to start or stop something dramatic, treat it as a prompt to look closer, not to act immediately, and for anything affecting your own health, your GP or pharmacist is a better guide than a headline. This is especially true for anything you might buy or stop taking on the back of a story. If a report makes you want to change a prescribed medicine, for instance, that is a conversation to have with your prescriber rather than a decision to make from an article, in the same way we would never suggest acting on GLP-1 side effect reports without clinical advice. A useful final habit is simply to wait: if a finding is real and important, it will still be there in a few months, backed by more than one study, and the initial noise will have settled into something you can actually rely on.
